MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)

NCT00857311 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

BIOLOGICAL: MRKAd5 HIV-1 gag vaccine (V520)
BIOLOGICAL: Comparator: Placebo
BIOLOGICAL: Comparator: Open Label Tetanus and Diptheria Toxoids Adsorbed
BIOLOGICAL: MRKAd5 HIV-1 gag vaccine (V520)

Sponsor

Merck Sharp & Dohme LLC